Dineras is compliant with the highest GDP standards of quality and integrity in distribution of pharmaceuticals. We use products sourced from reliable and respectable suppliers to ensure credibility, quality and traceability.

Compliance of Dineras to all GDP requirements and procedures is being assessed on a continuous basis by regulatory audits.

The most recent internal audit of Dineras was successfully passed in February, 2023. Dineras is accredited to supply large international CROs.

Dineras is a member of the Affordable Medicines Europe (AME), highlighting our commitment to the best standards in pharmaceutical distribution.

Dineras has been inspected under national inspection program in accordance with Art. 77(1) of Directive 2001/83/EC transposed in the Lithuanian legislation. Inspection was conducted on 09/11/2018 and it was considered that Dineras complies with the Good Distribution Practice requirements laid down in Article 84 of Directive 2001/83/EC.

Dineras fully comply with all rights and obligations arising from the Falsified Medicines Directive (Directive 2011/62/EU) and the Delegated Regulation (2016/161) by 9 February 2019.